Cognitive Functions under Anti-HER2 Targeted Therapy in Cancer Patients: A Scoping Review.
CONCLUSIONS: More studies analyzing the impact of anti-HER2 therapy on cognitive function are necessary at preclinical and clinical levels in order to personalize pharmacological treatment and offers cancer patients a better quality of life.
PMID: 32727341 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Endocrinology Authors: García-Sánchez J, Torregrosa MD, Cauli O Tags: Endocr Metab Immune Disord Drug Targets Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Chemotherapy | Databases & Libraries | Endocrinology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin | Science | Study